Glutamine enters tumor cells by SLC1A5 (ASCT2), SLC38A1, SLC38A2, SLC6A14 (ATB0+), and SLC6A19 (B0AT1), which are frequently overexpressed in different malignancies [73] (Figure 4). This evidence concerns the gene SLC1A5 and neoplasm.